Nystagmus, Congenital Medication
- Author: Theodore Curtis, MD; Chief Editor: Hampton Roy Sr, MD more...
Medication Summary
The only drugs used in the management of nystagmus are not useful in infants but are useful in adults with persistent nystagmus in which the motility disturbance itself is believed to cause visual impairment or other undesirable symptoms.
Anticonvulsants
Class Summary
Agents acting through gabapentin binding sites that may activate voltage-gated calcium channels may be useful in treating nystagmus.
Gabapentin (Neurontin)
Has been shown to be useful in some adults with congenital nystagmus in improving symptoms. No studies have been done in children to date. Exact mechanism of action is unknown but thought to be due to its antiglutamatergic activity. Has been used successfully to treat adult acquired nystagmus in multiple sclerosis.
Skeletal muscle relaxants
Class Summary
Agents used to treat reversible or intractable spasticity are helpful.
Baclofen (Lioresal)
May be effective in reducing nystagmus in adult patients with a history of idiopathic infantile nystagmus. Exact therapeutic mechanism unknown but may relate to inhibition of glutamate release rather than augmentation of GABA-ergic pathways as originally believed. It has been used to treat several types of nystagmus, most commonly PAN.
Improvements in nystagmus intensity appear within minutes and regress after several hours. Medication should not be taken at bedtime or other times when use of eyes is not anticipated.
Neuromuscular Blocking Agents, Toxin
Class Summary
Agents that produce a state of muscle denervation are helpful.
OnabotulinumtoxinA (BOTOX®)
Used in treatment of nystagmus by injection into specific extraocular muscles and retrobulbar placement within the muscle cone.
Hackett A, Tarpey PS, Licata A, Cox J, Whibley A, Boyle J, et al. CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes. Eur J Hum Genet. Dec 23 2009;[Medline].
McLean R, Proudlock F, Thomas S, Degg C, Gottlob I. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin. Ann Neurol. Feb 2007;61(2):130-8. [Medline].
Hertle RW, Dell'Osso LF, FitzGibbon EJ, Yang D, Mellow SD. Horizontal rectus muscle tenotomy in children with infantile nystagmus syndrome: a pilot study. J AAPOS. Dec 2004;8(6):539-48. [Medline].
Hertle RW, Felius J, Yang D, Kaufman M. Eye muscle surgery for infantile nystagmus syndrome in the first two years of life. Clin Ophthalmol. 2009;3:615-24. [Medline].
Arnoldi KA, Tychsen L. Prevalence of intracranial lesions in children initially diagnosed with disconjugate nystagmus (spasmus nutans) [published erratum appears in J Pediatr Ophthalmol Strabismus 1995 Nov- Dec;32(6):347]. J Pediatr Ophthalmol Strabismus. Sep-Oct 1995;32(5):296-301. [Medline].
Cabot A, Rozet JM, Gerber S, et al. A gene for X-linked idiopathic congenital nystagmus (NYS1) maps to chromosome Xp11.4-p11.3. Am J Hum Genet. Apr 1999;64(4):1141-6. [Medline].
Golubovic S, Marjanovic S, Cvetkovic D, Manic S. The application of hard contact lenses in patients with congenital nystagmus. Fortschr Ophthalmol. 1989;86(5):535-9. [Medline].
Harris C, Berry D. A developmental model of infantile nystagmus. Semin Ophthalmol. 2006;21:63-9. [Medline].
Helveston EM, Ellis FD, Plager DA. Large recession of the horizontal recti for treatment of nystagmus. Ophthalmology. Aug 1991;98(8):1302-5. [Medline].
Hertle RW, Zhu X. Oculographic and clinical characterization of thirty-seven children with anomalous head postures, nystagmus, and strabismus: the basis of a clinical algorithm. J AAPOS. Feb 2000;4(1):25-32. [Medline].
Lennerstrand G, Nordbo OA, Tian S, et al. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand. Feb 1998;76(1):27-7. [Medline].
Mezawa M, Ishikawa S, Ukai K. Changes in waveform of congenital nystagmus associated with biofeedback treatment. Br J Ophthalmol. Aug 1990;74(8):472-6. [Medline].
Miura K, Hertle RW, FitzGibbon EJ. Effects of tenotomy surgery on congenital nystagmus waveforms in adult patients. Part II. Dynamical systems analysis. Vision Res. Oct 2003;43(22):2357-62. [Medline].
Pratt-Johnson JA. Results of surgery to modify the null-zone position in congenital nystagmus. Can J Ophthalmol. Jun 1991;26(4):219-23. [Medline].
Reinecke RD. Costenbader Lecture. Idiopathic infantile nystagmus: diagnosis and treatment. J AAPOS. Jun 1997;1(2):67-82. [Medline].
Sarvananthan N, Proudlock FA, Choudhuri I. Pharmacologic treatment of congenital nystagmus. Arch Ophthalmol. 2006;124:916-8. [Medline].
Sprunger DT, Wasserman BN, Stidham DB. The relationship between nystagmus and surgical outcome in congenital esotropia. J AAPOS. Feb 2000;4(1):21-4. [Medline].

